학술논문

The optimal duration of immune checkpoint inhibitors in non-oncogene addicted non-small cell lung cancer: less is more? An open question
Document Type
Letter
Source
In: Recenti Progressi in Medicina. (Recenti Progressi in Medicina, December 2021, 112(12):802-804)
Subject
Language
English
ISSN
20381840
00341193